Published in Circulation on June 14, 2004
Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities. J Clin Invest (2006) 4.50
Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies. PLoS Med (2011) 2.64
Myocardial infarction and individual nonsteroidal anti-inflammatory drugs meta-analysis of observational studies. Pharmacoepidemiol Drug Saf (2013) 2.15
Discontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary care. BMJ (2011) 2.01
Risk of acute myocardial infarction with nonselective non-steroidal anti-inflammatory drugs: a meta-analysis. Arthritis Res Ther (2006) 1.96
Recent developments in nitric oxide donor drugs. Br J Pharmacol (2007) 1.94
Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials. Ann Rheum Dis (2007) 1.68
Obesity and the risk of psoriatic arthritis: a population-based study. Ann Rheum Dis (2012) 1.63
Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases. J Am Med Inform Assoc (2010) 1.62
Measuring additive interaction using odds ratios. Epidemiol Perspect Innov (2006) 1.41
Ibuprofen: pharmacology, efficacy and safety. Inflammopharmacology (2009) 1.19
Long-term use of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction in the general population. BMC Med (2005) 1.08
NSAID use selectively increases the risk of non-fatal myocardial infarction: a systematic review of randomised trials and observational studies. PLoS One (2011) 1.04
Risk of new acute myocardial infarction hospitalization associated with use of oral and parenteral non-steroidal anti-inflammation drugs (NSAIDs): a case-crossover study of Taiwan's National Health Insurance claims database and review of current evidence. BMC Cardiovasc Disord (2012) 0.98
Constituent country inequalities in myocardial infarction incidence and case fatality in men and women in the United Kingdom, 1996-2005. J Public Health (Oxf) (2010) 0.98
Traditional nonsteroidal anti-inflammatory drugs and postmenopausal hormone therapy: a drug-drug interaction? PLoS Med (2007) 0.95
Increased risk of myocardial infarction as first manifestation of ischaemic heart disease and nonselective nonsteroidal anti-inflammatory drugs. Br J Clin Pharmacol (2006) 0.93
Total joint arthroplasty and the risk of myocardial infarction: a general population, propensity score-matched cohort study. Arthritis Rheumatol (2015) 0.92
The coxibs and traditional nonsteroidal anti-inflammatory drugs: a current perspective on cardiovascular risks. Can J Cardiol (2007) 0.92
Risk of myocardial infarction and overall mortality in survivors of venous thromboembolism. Thromb J (2008) 0.91
The risk of cardiovascular disease in systemic sclerosis: a population-based cohort study. Ann Rheum Dis (2012) 0.90
Selective COX-2 inhibitors, NSAIDs and cardiovascular events - is celecoxib the safest choice? Ther Clin Risk Manag (2007) 0.87
Usage patterns of 'over-the-counter' vs. prescription-strength nonsteroidal anti-inflammatory drugs in France. Br J Clin Pharmacol (2014) 0.86
Use of non-steroidal anti-inflammatory drugs and risk of incident myocardial infarction and heart failure, and all-cause mortality in the Australian veteran community. Br J Clin Pharmacol (2010) 0.85
Cardiovascular risk with cyclooxygenase inhibitors: general problem with substance specific differences? Naunyn Schmiedebergs Arch Pharmacol (2006) 0.83
[Problems of pain measurement and pain therapy in the elderly]. Wien Med Wochenschr (2010) 0.83
Improved survival in rheumatoid arthritis: a general population-based cohort study. Ann Rheum Dis (2016) 0.82
Rehabilitation after hip fracture. Wien Med Wochenschr (2013) 0.78
[Analgesics in geriatric patients. Adverse side effects and interactions]. Z Gerontol Geriatr (2015) 0.76
PharmGKB summary: ibuprofen pathways. Pharmacogenet Genomics (2015) 0.75
Statin prescribing for people with severe mental illnesses: a staggered cohort study of 'real-world' impacts. BMJ Open (2017) 0.75
Cardiovascular safety of celecoxib in acute myocardial infarction patients: a nested case-control study. Heart Int (2009) 0.75
Meloxicam and risk of myocardial infarction: a population-based nested case-control study. Rheumatol Int (2017) 0.75
Using Multiple Pharmacovigilance Models Improves the Timeliness of Signal Detection in Simulated Prospective Surveillance. Drug Saf (2017) 0.75
[Polypharmacy and pain treatment]. Wien Med Wochenschr (2010) 0.75
NIMRA-survey: NSAIDs impact on mortality. Results of an Austrian Survey in 2006. Wien Med Wochenschr (2008) 0.75
Antithrombotic drugs and risk of hemorrhagic stroke in the general population. Neurology (2013) 2.85
Validation of ICD-9 codes with a high positive predictive value for incident strokes resulting in hospitalization using Medicaid health data. Pharmacoepidemiol Drug Saf (2008) 2.46
Myocardial infarction and individual nonsteroidal anti-inflammatory drugs meta-analysis of observational studies. Pharmacoepidemiol Drug Saf (2013) 2.15
Cardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart disease. Circ Cardiovasc Qual Outcomes (2009) 1.90
Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction. Basic Clin Pharmacol Toxicol (2006) 1.90
Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population. Am J Kidney Dis (2005) 1.89
Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants. Am J Gastroenterol (2007) 1.67
Risk of serious ventricular arrhythmia and sudden cardiac death in a cohort of users of domperidone: a nested case-control study. Pharmacoepidemiol Drug Saf (2010) 1.64
A method for detecting epistasis in genome-wide studies using case-control multi-locus association analysis. BMC Genomics (2008) 1.64
Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project). Drug Saf (2012) 1.50
Hormone therapy and cerebrovascular events: a population-based nested case-control study. Menopause (2006) 1.43
Genetic structure of the Spanish population. BMC Genomics (2010) 1.34
Incidence of hemorrhagic stroke in the general population: validation of data from The Health Improvement Network. Pharmacoepidemiol Drug Saf (2012) 1.34
The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study. J Alzheimers Dis (2010) 1.19
An entropy test for single-locus genetic association analysis. BMC Genet (2010) 1.15
Inverse association between nonsteroidal anti-inflammatory drugs and prostate cancer. Cancer Epidemiol Biomarkers Prev (2004) 1.11
Long-term use of non-steroidal anti-inflammatory drugs and the risk of myocardial infarction in the general population. BMC Med (2005) 1.08
NSAID use selectively increases the risk of non-fatal myocardial infarction: a systematic review of randomised trials and observational studies. PLoS One (2011) 1.04
CALHM1 P86L polymorphism is associated with late-onset Alzheimer's disease in a recessive model. J Alzheimers Dis (2010) 1.03
GOLPH2 gene markers are not associated with Alzheimer's disease in a sample of the Spanish population. J Alzheimers Dis (2009) 1.02
Use of oral corticosteroids and the risk of acute myocardial infarction. Atherosclerosis (2006) 1.02
The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's disease. Genome Med (2011) 0.98
Evaluation of varenicline as an aid to smoking cessation in UK general practice - a THIN database study. Curr Med Res Opin (2010) 0.95
Genome-wide association study of multiple sclerosis confirms a novel locus at 5p13.1. PLoS One (2012) 0.90
WWOX gene is associated with HDL cholesterol and triglyceride levels. BMC Med Genet (2010) 0.88
Quantitative assessment of the gastrointestinal and cardiovascular risk-benefit of celecoxib compared to individual NSAIDs at the population level. Pharmacoepidemiol Drug Saf (2007) 0.86
Genetic association of complement receptor 1 polymorphism rs3818361 in Alzheimer's disease. Alzheimers Dement (2011) 0.86
The safety of rosuvastatin in comparison with other statins in over 25,000 statin users in the Saskatchewan Health Databases. Pharmacoepidemiol Drug Saf (2008) 0.83
Exploratory analysis of seven Alzheimer's disease genes: disease progression. Neurobiol Aging (2012) 0.82
Interaction between Calpain 5, Peroxisome proliferator-activated receptor-gamma and Peroxisome proliferator-activated receptor-delta genes: a polygenic approach to obesity. Cardiovasc Diabetol (2008) 0.81
Migraine and risk of hemorrhagic stroke: a study based on data from general practice. J Headache Pain (2014) 0.81
Estrogen receptor alpha gene variants are associated with Alzheimer's disease. Neurobiol Aging (2010) 0.80
The MTHFD1L gene rs11754661 marker is not associated with Alzheimer's disease in a sample of the Spanish population. J Alzheimers Dis (2011) 0.80
Genetic study of neurexin and neuroligin genes in Alzheimer's disease. J Alzheimers Dis (2013) 0.80
Patterns in the use of low-dose acetylsalicylic acid and other therapies following upper gastrointestinal bleeding. Am J Cardiovasc Drugs (2014) 0.79
Calpain 10 gene and laryngeal cancer: a survival analysis. Head Neck (2011) 0.79
A digenic combination of polymorphisms within ESR1 and ESR2 genes are associated with age at menarche in the Spanish population. Reprod Sci (2008) 0.78
Prevalence of gastrointestinal stromal tumour (GIST) in the United Kingdom at different therapeutic lines: an epidemiologic model. BMC Cancer (2014) 0.76
"Does replication groups scoring reduce false positive rate in SNP interaction discovery? Response". BMC Genomics (2010) 0.75
NSAIDs and the risk of acute myocardial infarction. Nat Clin Pract Rheumatol (2007) 0.75
Weighting the effect of CYP19A gene in bone mineral density of postmenopausal women. Bone (2005) 0.75
Treatment and referral patterns for psoriasis in United Kingdom primary care: a retrospective cohort study. BMC Dermatol (2013) 0.75
Prevalence of glucose metabolism abnormalities and cardiovascular co-morbidity in the US elderly adult population. Pharmacoepidemiol Drug Saf (2006) 0.75
Rosuvastatin safety: a comprehensive, international pharmacoepidemiology programme. Pharmacoepidemiol Drug Saf (2006) 0.75
[Not Available]. Reumatol Clin (2008) 0.75
Treatment patterns and therapy effectiveness in psoriasis patients initiating biologic therapy in England. J Dermatolog Treat (2013) 0.75